Adverum Biotechnologies Stock Price. Everything You Need To Know About The Adverum Biotechnologies Stock!
Adverum Biotechnologies, Inc. is a leading player in the gene therapy industry, with a focus on developing innovative treatments for ocular and rare diseases. With its headquarters in Redwood City, California, the company has been making waves since its IPO in 2014.
One of Adverum’s most promising gene therapy product candidates is ADVM-022, which is designed to provide patients with wet age-related macular degeneration (wet AMD) with a sustainable treatment option. By delivering long-term, durable levels of aflibercept through a single intravitreal (IVT) injection, ADVM-022 helps reduce the treatment burden and fluctuations in macular fluid associated with frequent anti-VEGF therapy injections. This potentially improves patient outcomes and quality of life.
Adverum’s portfolio also includes ADVM-062 (AAV.7m8-L-opsin), a gene therapy product candidate that delivers a functional copy of the OPN1LW gene to the foveal cones of patients with blue cone monochromacy (BCM). This rare genetic condition can cause severe vision impairment, and ADVM-062 offers a potential treatment option via a single IVT injection.
As investors consider the potential of Adverum Biotechnologies, it’s important to keep track of stock price movements and stock price today, as well as premarket trends. Shares in the company may be affected by news and events in the gene therapy industry, and market cap can also be a useful metric to consider. However, we don’t offer specific investment advice or recommend this stock over others. As with any investment opportunity, conducting thorough research and consulting with a financial advisor is crucial to making informed decisions.
Adverum Biotechnologies Stock Price. Everything You Need To Know About The Adverum Biotechnologies Stock! performance
- Employees 123
- Company HQ Redwood City
- Website https://adverum.com/
- ADVM Asset Type Common Stock
- ADVM Market Capitalization 190.7M
- Earnings Per Share -11.6
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Adverum Biotechnologies! As an innovative biotech company, Adverum is dedicated to developing transformative gene therapies for patients with serious eye diseases. But how can you invest in Adverum Biotechnologies from the comfort of your own home? At Zorion, we offer a user-friendly investment platform where you can easily buy and sell stocks, including Adverum Biotechnologies. With our investment insights and recommendations tailored to investors from Malaysia, Thailand, Indonesia, and Vietnam, you can make informed decisions about your investments. Not only that, but we also provide a wealth of resources and educational materials to help you deepen your investment knowledge. So, whether you’re a seasoned investor or just starting out, Zorion has got you covered. Start investing in Adverum Biotechnologies today and unleash the potential of your investments!
